The importance of this neomorphic IDH2 activity for the cancer phenotype is valid even without consideration of d-2-hydroxyglutarate interference with epigenetics and the HIF pathway, because IDH2 depletes 2OG from the Krebs cycle. This evidence concerns the gene IDH2 and cancer.